CEU 2018 Session Recordings

Keep your endocrine practice up-to-date with Clinical Endocrinology Update (CEU) Session Recordings. This activity provides the latest information available in clinical endocrinology. Taught by expert faculty in a dynamic meeting format, you will finish viewing the CEU Session Recordings confident that your endocrine practice benefits from the most current and advanced information possible.  Purchase access to the CEU 2018 Session Recordings today!

To purchase access to the CEU 2018 Session Recordings activity, visit the Endocrine Society Online Store by clicking the button below.

Go to Endocrine Society Store

Access the latest clinical endocrine updates

Earn AMA PRA Category 1 Credits

Download mp3 audio files to listen on the go

Learning Objectives

Upon completion of this educational activity, learners will be better able to:

  • Discuss state-of-the-art research in endocrinology
  • Demonstrate updated knowledge of the pathophysiology, diagnosis, and treatment of diabetes, obesity, cardiovascular disease, dyslipidemia, as well as adrenal, metabolic, bone, pediatric, pituitary, thyroid, and reproductive endocrine disorders
  • Employ enhanced skills and practice management techniques to improve patient care

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Systems-based Practice
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
Endocrine Disruptors
Quality Improvement and Healthcare Delivery
General Endocrinology
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Pediatric Endocrinology
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Course opens: 
Course expires: 
CategorySession TitleFeatured SpeakerSession Duration
AdrenalMTP #12: Adrenal ImagingRichard Auchus  MD, PhD0:45
AdrenalCongenital Adrenal Hyperplasia: Diagnosis and TreatmentRichard Auchus  MD, PhD0:30
AdrenalAdrenal Fatigue and Failure: Fantasy and FactsJames Findling  MD0:30
AdrenalAdrenal Case PresentationsJanet Schlechte MD0:30
AdrenalQ&A/Panel DiscussionJanet Schlechte  MD0:20
AdrenalMTP #10: Updates in Pheochromocytoma and ParagangliomaAnand Vaidya  MD MMSc0:45
Bone and CalciumTreatment Goals in Osteoporosis: Is No Fracture the Only Marker of SuccessCarolyn Becker  MD0:30
Bone and CalciumMTP #1: New Enhancements to DXA and FRAX: A Case-based ApproachCarolyn Becker  MD0:45
Bone and CalciumHypophosphatemic Disorders and their ManagementSuzanne Jan de Beur  MD0:30
Bone and CalciumQ&A/Panel DiscussionSuzanne Jan de Beur MD0:15
Bone and CalciumOsteoporosis: Answers to Patients’ QuestionsAnn Kearns  MD, PhD0:30
Calcium and BoneUpdate on the Management of Renal Bone DiseaseRobert Wermers  MD0:30
Calcium and BoneMTP #2: Clinical Pearls in HypercalcemiaRobert Wermers  MD0:45
Cardiovascular EndocrinologyDiabetes and Heart FailureMatthew Cavender  MD, MPH0:30
Cardiovascular EndocrinologyQ&A/Panel DiscussionMatthew Cavender  MD, MPH0:15
Cardiovascular EndocrinologyUsing New and Emerging Therapies in Managing of HypercholesterolemiaIra Goldberg  MD0:30
Cardiovascular EndocrinologyMTP #4: Risk Stratification: Coronary Calcium, ApoB, LDL Particle Size, Lp(a). Which Ones are Worthwhile and Why?Ira Goldberg  MD0:45
DiabetesWhat’s New in Continuous Glucose Monitoring?Anders Carlson  MD0:30
DiabetesRenal Outcomes and New Diabetes MedicationsMark Molitch  MD0:45
DiabetesMTP #11: A New Era for Diabetic KetoacidosisMark Molitch  MD0:45
DiabetesDiabete$: Patient$, Doctor$, Insurer$, Manufacturer$, and $ocietyAlvin Powers  MD0:30
DiabetesMTP #9: Beta-Cell Replacement Therapy for Type 1 DiabetesMichael Rickels  MD0:45
DiabetesMTP #8: Update on Diabetic RetinopathySharon Solomon  MD0:45
DiabetesWhat’s Next after Basal InsulinCarol Wysham  MD0:30
DiabetesMTP #7: How I Use Concentrated InsulinsCarol Wysham  MD0:45
Female ReproMenopausal Hormone Therapy and AlternativesMargaret Wierman  MD0:30
Female ReproQ&A/Panel DiscussionMargaret Wierman  MD0:20
Female ReproHyperandrogenic Anovulation: PCOS and TumorsMargaret Wierman  MD0:30
Female ReproQ&A/Panel DiscussionMargaret Wierman  MD0:15
Transgender MedicineMTP #5: Transgender Women: Evaluation and ManagementJoshua Safer  MD0:45
Male reproductionMTP #6: Testosterone Replacement CasesBradley Anawalt  MD0:45
Male reproductionCased-based Debate of Whether to Start Testosterone Therapy and How to MonitorBradley Anawalt  MD0:30
Male reproductionPros and Cons with Non-Insulin Therapies in Gestational DiabetesLinda Barbour  MD, MSPH0:30
Male reproductionQ&A/Panel DiscussionLinda Barbour  MD, MSPH0:15
Male reproductionObesity-Related Low TestosteroneShehzad Basaria  MD, MBBS0:30
Neuroendocrine and PituitaryTreatment of Cushing Disease when Surgery Fails: Individualized Case-based ApproachJames Findling  MD0:30
Neuroendocrine and PituitaryTreatment with Anti-PD-1/PD-L1 and Anti-CTLA-4 Drugs: Endocrine Side EffectsMaria Fleseriu  MD0:30
Neuroendocrine and PituitaryMTP #14: Management of Women with Hypopituitarism to Conceive and During PregnancyMaria Fleseriu  MD0:45
Neuroendocrine and PituitaryMedical Treatment of Acromegaly: A Stepwise ApproachShlomo Melmed  MD0:30
Neuroendocrine and PituitaryQ&A/Panel DiscussionShlomo Melmed  MD0:15
Neuroendocrine and PituitaryMTP #13: Imaging-based Differential Diagnosis and Management of Pituitary MassesShlomo Melmed  MD0:45
ObesityPharmacotherapy for ObesityMarc-Andre Cornier  MD0:30
ObesityMTP #3: What’s New in Weight Loss Diets?Marc-Andre Cornier  MD0:45
ObesityManagement of the Patient Before and After Bariatric SurgeryChristopher Still  DO0:30
ObesityQ&A/Panel DiscussionChristopher Still  DO0:15
ThyroidMTP #16: Indications and Consequences of High-Dose LT4 TherapyKristien Boelaert  MD, PhD0:45
ThyroidSubclinical Thyroid DisordersKristien Boelaert  MD, PhD0:30
ThyroidQ&A/Panel DiscussionKristien Boelaert  MD, PhD0:15
ThyroidChallenging Thyroid Cases with Faculty PanelKristien Boelaert  MD, PhD0:45
ThyroidMTP #15: NIFTPThomas Giordano  MD, PhD0:45
ThyroidPapillary Thyroid MicrocarcinomasMegan Haymart  MD0:30
ThyroidOverview of Thyroid NodulesSusan Mandel  MD, MPH0:30

Disclosure Policy

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to The Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. 

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

To view disclosure information for all CEU presenters, please view the full Disclaimers and Disclosures page here


The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.


The educational content in this self-assessment test relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.


When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.


The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.


The Endocrine Society is proud to partner with industry to advance excellence and promote scientific discovery, medical practice and human health.:

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.The Endocrine Society designates this enduring activity for a maximum of 28.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

Accreditation Period

Course opens: 
Course expires: 



Check the boxes corresponding to the Session Recording topical courses in which you would like to enroll, then click the Enroll button.

If you are already enrolled, click the name of the topical course to go to that course.